The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in patients with and without prior immune dysfunction who survive sepsis from Staphylococcus aureus bacteremia. We hypothesize that patients with prior immune dysfunction will have greater reductions in HLA-DR and other markers of immune function after an episode of sepsis than people who do not have prior immune dysfunction.
Study Type
OBSERVATIONAL
Enrollment
102
University of Chicago Hospital
Chicago, Illinois, United States
HLA-DR and cytokines
Percent expression of HLA-DR on monocytes will be measured by flow cytometry. Cytokine levels will be measured by ELISA.
Time frame: 0-30 days
New Infections
Time frame: 0-90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.